Trial
NCT07433062
A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With Type 2 Diabetes Mellitus
Phase ISUSPENDEDSAFETYConfidence: MEDIUM
Sponsor
AstraZeneca
Collaborators
—
Condition
Type 2 Diabetes Mellitus
Intervention
AZD6793
Why stopped
Safety issue was identified in the Phase2b D7860C00006 study, evaluating AZD6793 in moderate to very severe COPD participants. D7860C00005 study is temporary halted to amend the design to reflect changes implemented in the ongoing D7860C00006 study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-22